Procedure
Axillary Reverse Mapping
Axillary Reverse Mapping is a medical procedure with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_2
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)
Trials by Status
completed250%
active_not_recruiting125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients
NCT05970107
active_not_recruitingphase_2
Axillary Reverse Mapping
NCT00572481
completednot_applicable
Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection
NCT04137744
completedphase_1
Axillary Reverse Mapping for Invasive Carcinoma of the Breast
NCT00645541
Clinical Trials (4)
Showing 4 of 4 trials
NCT05970107Not Applicable
Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients
NCT00572481Phase 2
Axillary Reverse Mapping
NCT04137744Not Applicable
Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection
NCT00645541Phase 1
Axillary Reverse Mapping for Invasive Carcinoma of the Breast
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4